Cargando…
PACAP activates MRGPRX2 on meningeal mast cells to drive migraine-like pain
Migraine ranks among the most prevalent disorders worldwide, leading to disability and decreased quality of life in patients. Recently, neurogenic inflammation has been recognized as a potential underlying pathology contributing to the migraine pain pathway. Mast cells reside in the meninges and hav...
Autores principales: | Sbei, Sami, Moncrief, Taylor, Limjunyawong, Nathachit, Zeng, Yaping, Green, Dustin P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387048/ https://www.ncbi.nlm.nih.gov/pubmed/37516794 http://dx.doi.org/10.1038/s41598-023-39571-y |
Ejemplares similares
-
Author Correction: PACAP activates MRGPRX2 on meningeal mast cells to drive migraine-like pain
por: Sbei, Sami, et al.
Publicado: (2023) -
Biological screening of a unique drug library targeting MRGPRX2
por: Yang, Fan, et al.
Publicado: (2022) -
Emerging Role of the Mast Cell–Microbiota Crosstalk in Cutaneous Homeostasis and Immunity
por: Bosveld, Cameron Jackson, et al.
Publicado: (2023) -
Therapeutic Potential of MRGPRX2 Inhibitors on Mast Cells
por: Ogasawara, Hiroyuki, et al.
Publicado: (2021) -
PACAP-38 and PACAP(6–38) Degranulate Rat Meningeal Mast Cells via the Orphan MrgB(3)-Receptor
por: Pedersen, Sara Hougaard, et al.
Publicado: (2019)